©2026 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission.
Tag: Innocan Pharma Corporation
Innocan Pharma Reports First Half Of 2025 Financial Results
HERZLIYA, Israel, and CALGARY, AB -- Innocan Pharma Corporation, a pharmaceutical technology company focusing on developing drug delivery platform technologies, reported its financial consolidated results for...
Innocan Pharma Files Registration Statement for Proposed U.S. Public Offering
HERZLIYA, Israel, and CALGARY, Alberta -- Innocan Pharma Corporation publicly filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (SEC)...
Innocan Pharma Reports First Quarter 2025 Financial Results
HERZLIYA, Israel, and CALGARY, AB -- Innocan Pharma Corporation reported its financial consolidated results for the first quarter ended March 31, 2025.
First Quarter 2025 Financial Highlights
Revenues increased...
Innocan Pharma Granted Mexican Patent for Topical Pain Relief Product
HERZLIYA, Israel, and CALGARY, AB -- The Mexican patent office has issued a notice of allowance for Innocan Pharma Corporation's patent application covering its proprietary topical pain-relief technology.
The...
Innocan Pharma Reports Full-Year 2024 Results
HERZLIYA, Israel, and CALGARY, Alberta -- Innocan Pharma Corporation, a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, reported its audited financial...
Innocan Pharma ClosesPrivate Placement for Gross Proceeds of C$635 Million
HERZLIYA, Israel, and CALGARY, Canada -- Innocan Pharma Corporation closed its previously announced non-brokered private placement offering of units of the Company, pursuant to which...
Innocan Pharma Closes Private Placement and Grants Stock Options
HERZLIYA, Israel, and CALGARY, Alberta -- Innocan Pharma Corporation, a pioneer in the pharmaceutical and biotechnology industries, completed its previously announced non-brokered private placement offering...
Innocan Pharma Reports First Quarter 2024 Results
HERZLIYA, Israel, and CALGARY, AB -- Innocan Pharma Corporation, a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, is pleased to announce...
Innocan Pharma Reports Full Year 2023 Results
HERZLIYA, Israel, and CALGARY, Alberta -- Innocan Pharma Corporation, a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies is pleased to announce...
Innocan Pharma Closes Private Placement for Gross Proceeds of Approximately C$2 Million
HERZLIYA, Israel, and CALGARY, Alberta -- Innocan Pharma Corporation closed its previously announced non-brokered private placement offering of units of the Company, pursuant to which the...